Concert Pharmaceuticals, Inc. Operating Margin 2014-2022 | CNCE
Current and historical operating margin for Concert Pharmaceuticals, Inc. (CNCE) over the last 10 years. The current operating profit margin for Concert Pharmaceuticals, Inc. as of September 30, 2022 is %.
| Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2022-09-30 | $0.00B | $-0.13B | inf% |
| 2022-06-30 | $0.00B | $-0.12B | -12200.00% |
| 2021-12-31 | $0.03B | $-0.08B | -236.36% |
| 2021-09-30 | $0.03B | $-0.07B | -203.03% |
| 2021-06-30 | $0.03B | $-0.06B | -173.53% |
| 2021-03-31 | $0.01B | $-0.08B | -975.00% |
| 2020-12-31 | $0.01B | $-0.07B | -912.50% |
| 2020-09-30 | $0.01B | $-0.07B | -900.00% |
| 2020-06-30 | $0.01B | $-0.07B | -1183.33% |
| 2020-03-31 | $0.00B | $-0.08B | inf% |
| 2019-12-31 | $0.00B | $-0.08B | -7800.00% |
| 2019-09-30 | $0.00B | $-0.08B | -7700.00% |
| 2019-06-30 | $0.00B | $-0.08B | -7600.00% |
| 2019-03-31 | $0.00B | $-0.07B | -7100.00% |
| 2018-12-31 | $0.01B | $-0.06B | -550.00% |
| 2018-09-30 | $0.01B | $-0.05B | -480.00% |
| 2018-06-30 | $0.15B | $0.10B | 65.58% |
| 2018-03-31 | $0.15B | $0.10B | 66.23% |
| 2017-12-31 | $0.14B | $0.09B | 64.58% |
| 2017-09-30 | $0.14B | $0.09B | 65.28% |
| 2017-06-30 | $0.00B | $-0.05B | inf% |
| 2017-03-31 | $0.00B | $-0.05B | inf% |
| 2016-12-31 | $0.00B | $-0.05B | inf% |
| 2016-09-30 | $0.01B | $-0.04B | -380.00% |
| 2016-06-30 | $0.01B | $-0.04B | -300.00% |
| 2016-03-31 | $0.07B | $0.02B | 30.77% |
| 2015-12-31 | $0.07B | $0.03B | 37.88% |
| 2015-09-30 | $0.06B | $0.02B | 26.32% |
| 2015-06-30 | $0.06B | $0.02B | 27.12% |
| 2015-03-31 | $0.01B | $-0.03B | -485.71% |
| 2014-12-31 | $0.01B | $-0.03B | -400.00% |
| 2014-09-30 | $0.01B | $-0.03B | -362.50% |
| 2014-06-30 | $0.01B | $-0.03B | -560.00% |
| 2014-03-31 | $0.02B | $-0.01B | -52.38% |
| 2013-12-31 | $0.03B | $-0.01B | -20.00% |
